Добавил:
Upload Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Large Scale Farming - ver 10.docx
Скачиваний:
1
Добавлен:
15.11.2019
Размер:
3.65 Mб
Скачать

Financials

Income statement*, usd mln

 

2009

2010

2011E

2012E

2013E

2014E

2015E

2016E

2017E

2018E

2019E

2020E

Net Revenues

14

16

18

31

42

50

52

54

56

59

61

64

Change y-o-y

N/M

13%

16%

72%

35%

18%

5%

4%

4%

4%

4%

4%

Cost Of Sales

(7)

(5)

(6)

(13)

(18)

(21)

(22)

(23)

(24)

(24)

(24)

(25)

Gross Profit

7

11

12

18

24

28

30

31

33

35

37

39

SG&A

(1)

(1)

(1)

(2)

(3)

(4)

(4)

(4)

(5)

(5)

(5)

(5)

Other Operating Income, net

0

0

1

2

2

2

3

3

3

3

3

3

EBITDA

6

10

12

17

23

27

28

30

31

33

35

37

EBITDA margin. %

44%

64%

65%

55%

55%

54%

54%

55%

55%

56%

57%

58%

Depreciation

(1)

(1)

(2)

(4)

(5)

(5)

(5)

(6)

(6)

(6)

(7)

(8)

EBIT

5

9

10

14

18

22

23

24

25

27

28

29

EBIT margin. %

40%

60%

54%

44%

44%

44%

44%

44%

45%

45%

46%

46%

Finance Expense, net

(2)

(2)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

Other Income/(Expense)

(1)

-

-

-

-

-

-

-

-

-

-

-

PBT

3

8

9

13

17

21

22

23

24

26

27

28

Tax

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(1)

(1)

(1)

Effective tax rate

0%

0%

2%

2%

2%

2%

2%

2%

2%

2%

2%

2%

Extraordinary Income/(Loss)

(0)

(0)

-

-

-

-

-

-

-

-

-

-

Net Income

3

8

9

13

17

20

21

23

24

25

26

28

Net Margin. %

19%

50%

47%

40%

40%

41%

41%

42%

42%

43%

43%

43%

Dividend Declared

-

-

-

-

5

15

21

23

24

24

25

26

*All figures are net of remeasurement of agricultural produce and revaluation of biological assets

Balance sheet, USD mln

 

2009

2010

2011E

2012E

2013E

2014E

2015E

2016E

2017E

2018E

2019E

2020E

Current Assets

16

15

28

25

31

35

36

38

39

40

41

43

Cash & Equivalents

3

0

11

2

2

2

3

3

3

3

3

3

Trade Receivables

4

2

3

5

6

7

8

8

8

9

9

10

Inventories and biological assets

7

13

13

17

20

22

23

23

24

24

25

26

Other current assets

2

1

1

2

3

3

3

4

4

4

4

4

Fixed Assets

11

11

26

42

50

50

48

46

46

46

46

47

PP&E. net

5

5

20

36

45

44

43

41

40

40

40

40

Other Fixed Assets

6

6

6

6

6

6

6

5

6

6

6

6

Total Assets

26

26

54

67

81

85

85

84

85

86

88

89

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' Equity

5

12

45

58

70

75

75

75

75

76

77

79

Share Capital

1

3

37

37

37

37

37

37

37

37

37

37

Reserves and Other*

4

9

9

21

33

38

38

38

38

39

41

42

Current Liabilities

18

12

8

9

12

10

10

9

10

10

10

11

ST Interest Bearing Debt

11

5

5

5

8

8

7

6

7

7

7

7

Trade Payables

7

7

3

3

3

2

2

2

2

2

2

2

Other Current Liabilities

0

0

0

0

1

1

1

1

1

1

1

1

LT Liabilities

3

2

-

-

-

-

-

-

-

-

-

-

LT Interest Bearing Debt

3

2

-

-

-

-

-

-

-

-

-

-

Other LT

-

-

-

-

-

-

-

-

-

-

-

-

Total Liabilities & Equity

26

26

54

67

81

85

85

84

85

86

88

89

Net Debt, USD mln

11

8

(6)

4

6

5

4

4

4

4

4

4

*For forecasted periods, does not include the effect of remeasurement of agricultural produce and revaluation of biological assets

Cash flow statement, USD mln

 

2009

2010

2011E

2012E

2013E

2014E

2015E

2016E

2017E

2018E

2019E

2020E

Net Income

3

8

9

13

17

20

21

23

24

25

26

28

Depreciation

1

1

2

4

5

5

5

6

6

6

7

8

Non-operating & non-cash items

(2)

(11)

(9)

-

(0)

(0)

(0)

0

(0)

(0)

(0)

(0)

Changes in working capital

(0)

13

(5)

(6)

(6)

(4)

(1)

(1)

(1)

(1)

(1)

(1)

Operating Cash Flow

1

10

(4)

10

16

21

25

28

28

30

32

34

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Expenditures. net

(1)

(1)

(17)

(19)

(13)

(5)

(3)

(4)

(5)

(6)

(7)

(8)

Other Investments. net

0

0

-

-

-

-

-

-

-

-

-

-

Investing Cash Flow

(1)

(1)

(17)

(19)

(13)

(5)

(3)

(4)

(5)

(6)

(7)

(8)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Borrowings/(repayments)

0

(7)

(2)

0

3

(1)

(1)

(1)

1

(0)

0

0

Dividends Paid

-

-

-

-

(5)

(15)

(21)

(23)

(24)

(24)

(25)

(26)

Other

(1)

(5)

34

-

-

-

-

-

-

-

-

-

Financing Cash Flow

(1)

(12)

32

0

(2)

(16)

(22)

(23)

(23)

(24)

(25)

(26)

 

 

 

 

 

 

 

 

 

 

 

 

 

Beginning Cash Balance

3

3

0

11

2

2

2

3

3

3

3

3

Ending Cash Balance

3

0

11

2

2

2

3

3

3

3

3

3

Net Cash Inflows/Outflows

(0)

(3)

11

(9)

1

0

0

0

0

0

0

0

Source: Company data, Concorde Capital projections

Соседние файлы в предмете [НЕСОРТИРОВАННОЕ]